Liyan Qiu

4.7k citations
136 papers · 3.9k indexed · h-index 36

Impact in

Papers in

Liyan Qiu

131 papers receiving 3.8k citations

Peers

Liyan Qiu
Comparison fields: 5 of 138
  • Biomaterials 1.5k
  • Pharmaceutical Science 403
  • Molecular Medicine 224
  • Polymers and Plastics 443
  • Molecular Biology 1.5k
Replace Lixin Liu with:
Lixin Liu China
Peisheng Xu United States
Laiqiang Huang China
Juntao Luo United States
Kyung Hyun Min South Korea
Dongin Kim United States
Shuangjiang Yu China
Praveen Kumar Vemula India
Liyan Qiu relative to Lixin Liu China Lixin Liu's profile →
Citations per field
00.5×2.5×
Lixin Liu · 1×
Citations per year

Countries citing papers authored by Liyan Qiu

Since Specialization
Citations

This map shows the geographic impact of Liyan Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Qiu more than expected).

Fields of papers citing papers by Liyan Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyan Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Qiu. The network helps show where Liyan Qiu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Liyan Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Liyan Qiu Line = papers co-authored together Liyan Qiu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20250
3 20242
4 20244
5 20229
6 202146
7 20200
8 202012
9 201614
10 201641
11 201521
12 201541
13 2014114
14 201442
15 201213
16 201025
17 200954
18 20081
19 200857
20 200612

About Liyan Qiu

Liyan Qiu is a scholar working on Biomaterials, Pharmaceutical Science, Polymers and Plastics, Molecular Medicine and Molecular Biology, having authored 136 papers that have together received 3.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (46 papers), RNA Interference and Gene Delivery (25 papers), Nanoplatforms for cancer theranostics (18 papers), Flame retardant materials and properties (14 papers), Advanced Drug Delivery Systems (11 papers), Drug Transport and Resistance Mechanisms (11 papers), biodegradable polymer synthesis and properties (11 papers) and Dendrimers and Hyperbranched Polymers (10 papers). The work is most often cited by research in Biomaterials (1.5k citations), Pharmaceutical Science (403 citations), Molecular Medicine (224 citations), Polymers and Plastics (443 citations) and Molecular Biology (1.5k citations). Liyan Qiu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Qinghe Zhao, Cheng Zheng, Yu Yang, Mary Anne White, Yi Jin, Xiumei Zhu, Jing Xu, Kangjie Zhu, Lina Liang and Xiaoli Zhang. Their work appears in journals such as International Journal of Pharmaceutics, Nanomedicine Nanotechnology Biology and Medicine, Acta Biomaterialia, RSC Advances and Colloids and Surfaces B Biointerfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026